Antibiotice S.A. (BVB:ATB)
Romania · Delayed Price · Currency is RON 2.010
-0.030 (-1.47%)
At close: Jun 8, 2026
Antibiotice Cash Flow Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 31.69 | 51.77 | 102.2 | 81.09 | 51.47 | 29.94 |
Depreciation & Amortization | 55.71 | 54.2 | 45.06 | 27.93 | 22.57 | 24.43 |
Loss (Gain) From Sale of Assets | - | - | -0.16 | -0 | 2.75 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 3.04 | - |
Provision & Write-off of Bad Debts | -9.59 | -6.2 | 3 | -1.1 | -3.14 | - |
Other Operating Activities | -1.97 | 0.12 | -6.57 | 2.81 | 17.4 | -9.93 |
Change in Accounts Receivable | -6.32 | -5.15 | -65.3 | -30.64 | 75.98 | - |
Change in Inventory | -69.37 | -8.37 | -1.78 | -19.05 | -40.84 | - |
Change in Unearned Revenue | 0.02 | - | 0.16 | 0 | 0.03 | - |
Change in Other Net Operating Assets | 65.73 | -13.94 | 18.54 | 61.42 | -13.6 | - |
Operating Cash Flow | 65.9 | 72.44 | 95.15 | 122.46 | 115.66 | 44.44 |
Operating Cash Flow Growth | 8.79% | -23.87% | -22.30% | 5.88% | 160.28% | -52.75% |
Capital Expenditures | -172.16 | -142.61 | -98.77 | -83.03 | -37.58 | -29.05 |
Sale (Purchase) of Intangibles | -5.12 | - | -17.39 | -15.01 | -7.47 | - |
Other Investing Activities | 5.34 | 5.34 | - | - | - | - |
Investing Cash Flow | -171.94 | -137.27 | -116.16 | -98.04 | -45.05 | -29.05 |
Long-Term Debt Issued | - | 92.51 | 85.19 | - | - | - |
Long-Term Debt Repaid | - | - | -10.79 | -14.68 | -63.8 | -6.32 |
Net Debt Issued (Repaid) | 107.59 | 92.51 | 74.41 | -14.68 | -63.8 | -6.32 |
Common Dividends Paid | -15.93 | -15.95 | -48.17 | -5.43 | -3.43 | -2.1 |
Other Financing Activities | -5.08 | -4.46 | -4.61 | -4.09 | -3.53 | - |
Financing Cash Flow | 86.57 | 72.1 | 21.63 | -24.2 | -70.76 | -8.42 |
Foreign Exchange Rate Adjustments | 0.1 | - | 0.25 | -0.14 | -0.26 | -0.1 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | 0.02 | - |
Net Cash Flow | -19.38 | 7.26 | 0.87 | 0.08 | -0.38 | 6.87 |
Free Cash Flow | -106.26 | -70.17 | -3.63 | 39.43 | 78.09 | 15.39 |
Free Cash Flow Growth | - | - | - | -49.50% | 407.53% | -66.60% |
Free Cash Flow Margin | -16.63% | -10.63% | -0.53% | 6.41% | 15.46% | 4.06% |
Free Cash Flow Per Share | -0.16 | -0.10 | -0.01 | 0.06 | 0.12 | 0.02 |
Cash Interest Paid | 5.09 | 4.47 | 4.61 | 4.09 | 3.53 | 3.54 |
Cash Income Tax Paid | 6.64 | 6.64 | 3.72 | 13.02 | 3.93 | 3.61 |
Levered Free Cash Flow | -140.19 | -99.14 | -60.04 | -6 | 44.45 | 21.61 |
Unlevered Free Cash Flow | -137.31 | -96.34 | -57.2 | -3.4 | 46.69 | 23.81 |
Change in Working Capital | -9.93 | -27.46 | -48.38 | 11.73 | 21.57 | - |